Fakeeh Care Group intrinsic value and dividend analysis using DCF, P/B, PEG and PSG models. Includes dividend yield, payout ratio, and dividend sustainability assessment. Sector: Health Care Equipment & Svc. Listed on Saudi Exchange Tadawul.
Dr. Soliman Abdel Kader Fakeeh Hospital Company establishes and operates hospitals, clinics, and medical and educational centers in Saudi Arabia, covering specialties from cardiology and oncology to orthopedics and pediatric surgery. Its Trading, Retail & Others segment includes pharmaceutical and cosmetics trading and medical equipment maintenance. The company was incorporated in 1978 and is based in Jeddah.
TASIV estimates this company's intrinsic value using a DCF (Discounted Cash Flow) model. As of TASIV's most recent data refresh, the estimated intrinsic value is SAR 34.84 compared to a market price of SAR 38.46 (Trading near DCF model value). This is an analytical estimate, not investment advice.
Revenue increased by about 33% over the three-year period, while net income grew by a much smaller margin of approximately 4%, indicating that profitability grew far more slowly than sales. Operating cash flow increased by about 99% over the same period, well ahead of both revenue and net income growth. Overall, the company's historical financial performance shows a considerable increase in operating cash flow alongside meaningful revenue growth and comparatively marginal growth in net income.
Dividend per share held steady at SAR 0.3 for 1 consecutive years before rising to SAR 0.33 in the most recent year, an increase of about 10%. Payments have been made on an Annual basis throughout this period. Overall, the dividend held flat for most of the period before a recent increase. Current dividend yield is approximately 0.86%, with a payout ratio of approximately 26.38%.
TASIV's Competitive Advantage assessment for this company is High (77/100), based on profitability, predictability, financial strength, and growth resilience.
Based on TASIV's DCF (Discounted Cash Flow) model, the estimated intrinsic value of Fakeeh Care Group is approximately SAR 34.84, compared to a current market price of SAR 38.46. This is an analytical estimate based on the company's financial data, not investment advice or a recommendation to buy or sell.
According to TASIV's model, Fakeeh Care Group is currently "Trading near DCF model value".
Fakeeh Care Group's dividend yield is approximately 0.86%, with a payout ratio of approximately 26.38%, based on TASIV's most recent verified data.
Loading 4017...